摘要 |
The present invention relates to compounds of formula (I) wherein RI, R2, R3, R4 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the antagonism of the glucagon receptor, such as diabetes. |
申请人 |
F. HOFFMANN-LA ROCHE AG;ERICKSON, SHAWN, DAVID;GILLESPIE, PAUL;GUERTIN, KEVIN, RICHARD |
发明人 |
ERICKSON, SHAWN, DAVID;GILLESPIE, PAUL;GUERTIN, KEVIN, RICHARD |